Logo image of CNO

CNO FINANCIAL GROUP INC (CNO) Stock Fundamental Analysis

NYSE:CNO - New York Stock Exchange, Inc. - US12621E1038 - Common Stock - Currency: USD

39.62  -0.08 (-0.2%)

After market: 39.62 0 (0%)

Fundamental Rating

4

Overall CNO gets a fundamental rating of 4 out of 10. We evaluated CNO against 143 industry peers in the Insurance industry. While CNO is still in line with the averages on profitability rating, there are concerns on its financial health. CNO has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

CNO had positive earnings in the past year.
In the past year CNO had a positive cash flow from operations.
CNO had positive earnings in each of the past 5 years.
In the past 5 years CNO always reported a positive cash flow from operatings.
CNO Yearly Net Income VS EBIT VS OCF VS FCFCNO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M 600M 800M

1.2 Ratios

Looking at the Return On Assets, with a value of 1.07%, CNO is doing worse than 60.14% of the companies in the same industry.
Looking at the Return On Equity, with a value of 16.17%, CNO is in the better half of the industry, outperforming 67.13% of the companies in the same industry.
Industry RankSector Rank
ROA 1.07%
ROE 16.17%
ROIC N/A
ROA(3y)1.25%
ROA(5y)1.24%
ROE(3y)21.43%
ROE(5y)16.13%
ROIC(3y)N/A
ROIC(5y)N/A
CNO Yearly ROA, ROE, ROICCNO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30

1.3 Margins

Looking at the Profit Margin, with a value of 8.93%, CNO is in line with its industry, outperforming 57.34% of the companies in the same industry.
CNO's Profit Margin has declined in the last couple of years.
Looking at the Operating Margin, with a value of 17.41%, CNO is in the better half of the industry, outperforming 69.93% of the companies in the same industry.
CNO's Operating Margin has improved in the last couple of years.
Industry RankSector Rank
OM 17.41%
PM (TTM) 8.93%
GM N/A
OM growth 3Y-3.08%
OM growth 5Y9.46%
PM growth 3Y-13.73%
PM growth 5Y-2.56%
GM growth 3YN/A
GM growth 5YN/A
CNO Yearly Profit, Operating, Gross MarginsCNO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20

1

2. Health

2.1 Basic Checks

Compared to 1 year ago, CNO has less shares outstanding
The number of shares outstanding for CNO has been reduced compared to 5 years ago.
The debt/assets ratio for CNO is higher compared to a year ago.
CNO Yearly Shares OutstandingCNO Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
CNO Yearly Total Debt VS Total AssetsCNO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

2.2 Solvency

CNO has a debt to FCF ratio of 7.20. This is a slightly negative value and a sign of low solvency as CNO would need 7.20 years to pay back of all of its debts.
The Debt to FCF ratio of CNO (7.20) is worse than 69.23% of its industry peers.
CNO has a Debt/Equity ratio of 1.81. This is a high value indicating a heavy dependency on external financing.
The Debt to Equity ratio of CNO (1.81) is worse than 92.31% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.81
Debt/FCF 7.2
Altman-Z N/A
ROIC/WACCN/A
WACCN/A
CNO Yearly LT Debt VS Equity VS FCFCNO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
CNO Yearly Current Assets VS Current LiabilitesCNO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

5

3. Growth

3.1 Past

CNO shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 28.30%, which is quite impressive.
The Earnings Per Share has been growing by 16.49% on average over the past years. This is quite good.
CNO shows a small growth in Revenue. In the last year, the Revenue has grown by 7.33%.
The Revenue has been growing slightly by 2.35% on average over the past years.
EPS 1Y (TTM)28.3%
EPS 3Y12.53%
EPS 5Y16.49%
EPS Q2Q%11.02%
Revenue 1Y (TTM)7.33%
Revenue growth 3Y3.34%
Revenue growth 5Y2.35%
Sales Q2Q%-6.26%

3.2 Future

CNO is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 5.92% yearly.
Based on estimates for the next years, CNO will show a small growth in Revenue. The Revenue will grow by 3.30% on average per year.
EPS Next Y-3.44%
EPS Next 2Y2.87%
EPS Next 3Y5.92%
EPS Next 5YN/A
Revenue Next Year3.87%
Revenue Next 2Y3.36%
Revenue Next 3Y3.3%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CNO Yearly Revenue VS EstimatesCNO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1B 2B 3B 4B
CNO Yearly EPS VS EstimatesCNO Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1 2 3 4

5

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 9.93 indicates a reasonable valuation of CNO.
Compared to the rest of the industry, the Price/Earnings ratio of CNO indicates a somewhat cheap valuation: CNO is cheaper than 68.53% of the companies listed in the same industry.
When comparing the Price/Earnings ratio of CNO to the average of the S&P500 Index (29.35), we can say CNO is valued rather cheaply.
Based on the Price/Forward Earnings ratio of 10.28, the valuation of CNO can be described as reasonable.
CNO's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. CNO is cheaper than 61.54% of the companies in the same industry.
CNO's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 22.10.
Industry RankSector Rank
PE 9.93
Fwd PE 10.28
CNO Price Earnings VS Forward Price EarningsCNO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Compared to the rest of the industry, the Price/Free Cash Flow ratio of CNO indicates a somewhat cheap valuation: CNO is cheaper than 62.94% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 6.37
EV/EBITDA N/A
CNO Per share dataCNO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)0.6
EPS Next 2Y2.87%
EPS Next 3Y5.92%

5

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 1.61%, CNO has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 3.10, CNO has a dividend in line with its industry peers.
CNO's Dividend Yield is slightly below the S&P500 average, which is at 2.33.
Industry RankSector Rank
Dividend Yield 1.61%

5.2 History

The dividend of CNO is nicely growing with an annual growth rate of 8.19%!
CNO has paid a dividend for at least 10 years, which is a reliable track record.
CNO has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)8.19%
Div Incr Years12
Div Non Decr Years12
CNO Yearly Dividends per shareCNO Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6

5.3 Sustainability

16.76% of the earnings are spent on dividend by CNO. This is a low number and sustainable payout ratio.
The dividend of CNO is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP16.76%
EPS Next 2Y2.87%
EPS Next 3Y5.92%
CNO Yearly Income VS Free CF VS DividendCNO Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M 600M
CNO Dividend Payout.CNO Dividend Payout, showing the Payout Ratio.CNO Dividend Payout.PayoutRetained Earnings

CNO FINANCIAL GROUP INC

NYSE:CNO (3/7/2025, 8:15:36 PM)

After market: 39.62 0 (0%)

39.62

-0.08 (-0.2%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupInsurance
GICS IndustryInsurance
Earnings (Last)02-06 2025-02-06/amc
Earnings (Next)04-28 2025-04-28/amc
Inst Owners96.17%
Inst Owner Change-2.6%
Ins Owners2.35%
Ins Owner Change5.87%
Market Cap4.00B
Analysts69.09
Price Target44.37 (11.99%)
Short Float %2.29%
Short Ratio3.91
Dividend
Industry RankSector Rank
Dividend Yield 1.61%
Yearly Dividend0.64
Dividend Growth(5Y)8.19%
DP16.76%
Div Incr Years12
Div Non Decr Years12
Ex-Date03-10 2025-03-10 (0.16)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)27.77%
Min EPS beat(2)22.13%
Max EPS beat(2)33.4%
EPS beat(4)3
Avg EPS beat(4)20.52%
Min EPS beat(4)-20.49%
Max EPS beat(4)47.04%
EPS beat(8)5
Avg EPS beat(8)12.58%
EPS beat(12)7
Avg EPS beat(12)12.69%
EPS beat(16)11
Avg EPS beat(16)14.57%
Revenue beat(2)2
Avg Revenue beat(2)15.81%
Min Revenue beat(2)11.94%
Max Revenue beat(2)19.67%
Revenue beat(4)4
Avg Revenue beat(4)17.14%
Min Revenue beat(4)11.94%
Max Revenue beat(4)22.37%
Revenue beat(8)8
Avg Revenue beat(8)14.24%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)5.67%
PT rev (3m)9.85%
EPS NQ rev (1m)-0.03%
EPS NQ rev (3m)0.8%
EPS NY rev (1m)0.49%
EPS NY rev (3m)1.51%
Revenue NQ rev (1m)-0.01%
Revenue NQ rev (3m)0.12%
Revenue NY rev (1m)0.43%
Revenue NY rev (3m)0.63%
Valuation
Industry RankSector Rank
PE 9.93
Fwd PE 10.28
P/S 0.88
P/FCF 6.37
P/OCF 6.37
P/B 1.6
P/tB 1.6
EV/EBITDA N/A
EPS(TTM)3.99
EY10.07%
EPS(NY)3.85
Fwd EY9.72%
FCF(TTM)6.22
FCFY15.7%
OCF(TTM)6.22
OCFY15.7%
SpS44.86
BVpS24.77
TBVpS24.77
PEG (NY)N/A
PEG (5Y)0.6
Profitability
Industry RankSector Rank
ROA 1.07%
ROE 16.17%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM 17.41%
PM (TTM) 8.93%
GM N/A
FCFM 13.87%
ROA(3y)1.25%
ROA(5y)1.24%
ROE(3y)21.43%
ROE(5y)16.13%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)2.15%
ROCE(5y)1.99%
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-3.08%
OM growth 5Y9.46%
PM growth 3Y-13.73%
PM growth 5Y-2.56%
GM growth 3YN/A
GM growth 5YN/A
F-Score7
Asset Turnover0.12
Health
Industry RankSector Rank
Debt/Equity 1.81
Debt/FCF 7.2
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 250
Cash Conversion N/A
Profit Quality 155.37%
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score7
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)148.25%
Profit Quality(5y)158.67%
High Growth Momentum
Growth
EPS 1Y (TTM)28.3%
EPS 3Y12.53%
EPS 5Y16.49%
EPS Q2Q%11.02%
EPS Next Y-3.44%
EPS Next 2Y2.87%
EPS Next 3Y5.92%
EPS Next 5YN/A
Revenue 1Y (TTM)7.33%
Revenue growth 3Y3.34%
Revenue growth 5Y2.35%
Sales Q2Q%-6.26%
Revenue Next Year3.87%
Revenue Next 2Y3.36%
Revenue Next 3Y3.3%
Revenue Next 5YN/A
EBIT growth 1Y22.44%
EBIT growth 3Y0.16%
EBIT growth 5Y12.04%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y7.69%
FCF growth 3Y1.61%
FCF growth 5Y-2.06%
OCF growth 1Y7.69%
OCF growth 3Y1.61%
OCF growth 5Y-2.06%